These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10334933)

  • 1. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.
    Torréns I; Reyes O; Ojalvo AG; Seralena A; Chinea G; Cruz LJ; de la Fuente J
    Biochem Biophys Res Commun; 1999 May; 259(1):162-8. PubMed ID: 10334933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.
    Torréns I; Ojalvo AG; Seralena A; Pupo E; Lugo V; Páez R
    Biochem Biophys Res Commun; 1999 Dec; 266(1):230-6. PubMed ID: 10581194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequences of antigenic epitopes of streptokinase identified via random peptide libraries displayed on phage.
    Parhami-Seren B; Keel T; Reed GL
    J Mol Biol; 1997 Aug; 271(3):333-41. PubMed ID: 9268662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments.
    Reed GL; Kussie P; Parhami-Seren B
    J Immunol; 1993 May; 150(10):4407-15. PubMed ID: 8482842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-ceIl recognition of discrete regions of the thrombolytic drug streptokinase.
    Lawley WJ; Fletcher S; Squire IB; Woods KL; Hewitt CR
    Clin Sci (Lond); 2000 Sep; 99(3):239-46. PubMed ID: 11787478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.
    Reyes O; Torrens I; Ojalvo AG; Seralena A; Garay HE
    Mol Divers; 2004; 8(3):251-6. PubMed ID: 15384418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic.
    Torrèns I; Ojalvo AG; Seralena A; Hayes O; de la Fuente J
    Immunol Lett; 1999 Dec; 70(3):213-8. PubMed ID: 10656677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the antigenic regions of streptokinase in humans before and after streptokinase therapy.
    Parhami-Seren B; Lynch M; White HD; Reed GL
    Mol Immunol; 1995 Jul; 32(10):717-24. PubMed ID: 7659098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affinity panning of peptide libraries using anti-streptokinase monoclonal antibodies: selection of an inhibitor of plasmin(ogen) active site.
    Parhami-Seren B; Krudysz J; Tsantili P
    J Immunol Methods; 2002 Sep; 267(2):185-98. PubMed ID: 12165440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human anti-streptokinase antibodies induce platelet aggregation in an Fc receptor (CD32) dependent manner.
    Lebrazi J; Helft G; Abdelouahed M; Elalamy I; Mirshahi M; Samama MM; Lecompte T
    Thromb Haemost; 1995 Sep; 74(3):938-42. PubMed ID: 8571325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of circulating antibodies against a streptokinase C-terminal peptide in normal blood donors.
    Ojalvo AG; Pozo L; Labarta V; Torréns I
    Biochem Biophys Res Commun; 1999 Sep; 263(2):454-9. PubMed ID: 10491315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does intravenous streptokinase therapy facilitate the formation of anti-heart antibodies in acute myocardial infarction?
    Scolozzi R; Boccafogli A; Vicentini L; Masotti M; Baraldi A; Pradella A; Baggioni GF; Camerani A; Boniotti A
    Riv Eur Sci Med Farmacol; 1989 Aug; 11(4):297-300. PubMed ID: 2640051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mapping of FVIII inhibitor epitopes using cellulose-bound synthetic peptide arrays.
    Kopecky EM; Greinstetter S; Pabinger I; Buchacher A; Römisch J; Jungbauer A
    J Immunol Methods; 2006 Jan; 308(1-2):90-100. PubMed ID: 16376372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and induction of circulating antibodies against recombinant staphylokinase.
    Declerck PJ; Vanderschueren S; Billiet J; Moreau H; Collen D
    Thromb Haemost; 1994 Jan; 71(1):129-33. PubMed ID: 8165631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of anti-streptokinase antibody levels in human sera using a microradioimmunoassay procedure.
    Moran DM; Standring R; Lavender EA; Harris GS
    Thromb Haemost; 1984 Dec; 52(3):281-7. PubMed ID: 6531752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The spot technique: synthesis and screening of peptide macroarrays on cellulose membranes.
    Winkler DF; Campbell WD
    Methods Mol Biol; 2008; 494():47-70. PubMed ID: 18726568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of antigenic MUC1 peptides to breast cancer antibody fragment B27.29: a heteronuclear NMR study.
    Grinstead JS; Schuman JT; Campbell AP
    Biochemistry; 2003 Dec; 42(48):14293-305. PubMed ID: 14640698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronary thrombolysis and previous SK therapy.
    Massel D
    Can J Cardiol; 1993; 9(6):518-20. PubMed ID: 8221347
    [No Abstract]   [Full Text] [Related]  

  • 19. Different immune response of mice immunized with conjugates containing multiple copies of either consensus or mixotope versions of the V3 loop peptide from human immunodeficiency virus type 1.
    Cruz LJ; Iglesias E; Aguilar JC; Cabrales A; Reyes O; Andreu D
    Bioconjug Chem; 2004; 15(5):1110-7. PubMed ID: 15366967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-streptokinase antibodies].
    Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.